http://wiki.ch-chainclinic.com/index.php?action=history&feed=atom&title=%E9%9D%B6%E5%90%91%E8%8D%AF%E8%A1%8C%E4%B8%9A%E7%A0%94%E7%A9%B6
靶向药行业研究 - 版本历史
2026-04-11T21:56:35Z
本wiki的该页面的版本历史
MediaWiki 1.30.0
http://wiki.ch-chainclinic.com/index.php?title=%E9%9D%B6%E5%90%91%E8%8D%AF%E8%A1%8C%E4%B8%9A%E7%A0%94%E7%A9%B6&diff=11156&oldid=prev
2017年9月30日 (六) 08:04 Jianjdandd
2017-09-30T08:04:08Z
<p></p>
<table class="diff diff-contentalign-left" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr style="vertical-align: top;" lang="zh-CN">
<td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td>
<td colspan="2" style="background-color: white; color:black; text-align: center;">2017年9月30日 (六) 08:04的版本</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1" >第1行：</td>
<td colspan="2" class="diff-lineno">第1行：</td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">[[category:行业研究]]</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"><div style="max-width:73%;</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"> background-color:#C1FFC1;</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"> border:0px solid #000000;"></ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#史上最全癌症靶向药（2017版）  https://mp.weixin.qq.com/s/7mpVHYy4QV8DZZFrU5Nc8w</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#史上最全癌症靶向药（2017版）  https://mp.weixin.qq.com/s/7mpVHYy4QV8DZZFrU5Nc8w</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#Overview of Targeted Therapies for Cancer - My Cancer Genome  https://www.mycancergenome.org/content/molecular-medicine/overview-of-targeted-therapies-for-cancer</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#Overview of Targeted Therapies for Cancer - My Cancer Genome  https://www.mycancergenome.org/content/molecular-medicine/overview-of-targeted-therapies-for-cancer</div></td></tr>
<tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l17" >第17行：</td>
<td colspan="2" class="diff-lineno">第22行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#Pembrolizumab（派姆单抗），靶点PD-1，Pembrolizumab - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/pembrolizumab</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#Pembrolizumab（派姆单抗），靶点PD-1，Pembrolizumab - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/pembrolizumab</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#Bortezomib（硼替佐米），靶点Proteasome，中国已经上市 Bortezomib - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/bortezomib</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#Bortezomib（硼替佐米），靶点Proteasome，中国已经上市 Bortezomib - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/bortezomib</div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></div></ins></div></td></tr>
</table>
Jianjdandd
http://wiki.ch-chainclinic.com/index.php?title=%E9%9D%B6%E5%90%91%E8%8D%AF%E8%A1%8C%E4%B8%9A%E7%A0%94%E7%A9%B6&diff=11155&oldid=prev
2017年9月30日 (六) 08:03 Jianjdandd
2017-09-30T08:03:29Z
<p></p>
<table class="diff diff-contentalign-left" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr style="vertical-align: top;" lang="zh-CN">
<td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td>
<td colspan="2" style="background-color: white; color:black; text-align: center;">2017年9月30日 (六) 08:03的版本</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l2" >第2行：</td>
<td colspan="2" class="diff-lineno">第2行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#Overview of Targeted Therapies for Cancer - My Cancer Genome  https://www.mycancergenome.org/content/molecular-medicine/overview-of-targeted-therapies-for-cancer</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#Overview of Targeted Therapies for Cancer - My Cancer Genome  https://www.mycancergenome.org/content/molecular-medicine/overview-of-targeted-therapies-for-cancer</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#New FDA Approved Drugs for 2017 | CenterWatch  http://www.centerwatch.com/drug-information/fda-approved-drugs/</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#New FDA Approved Drugs for 2017 | CenterWatch  http://www.centerwatch.com/drug-information/fda-approved-drugs/</div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#A to Z List of Cancer Drugs - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs</ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===淋巴瘤===</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===淋巴瘤===</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#Ibrutinib（依鲁替尼），靶点BTK，Ibrutinib (PCI-32765) | BTK 抑制剂  http://www.selleck.cn/products/pci-32765.html Ibrutinib - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/ibrutinib</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#Ibrutinib（依鲁替尼），靶点BTK，Ibrutinib (PCI-32765) | BTK 抑制剂  http://www.selleck.cn/products/pci-32765.html Ibrutinib - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/ibrutinib</div></td></tr>
</table>
Jianjdandd
http://wiki.ch-chainclinic.com/index.php?title=%E9%9D%B6%E5%90%91%E8%8D%AF%E8%A1%8C%E4%B8%9A%E7%A0%94%E7%A9%B6&diff=11154&oldid=prev
Jianjdandd：/* 淋巴瘤 */
2017-09-30T08:00:19Z
<p><span dir="auto"><span class="autocomment">淋巴瘤</span></span></p>
<table class="diff diff-contentalign-left" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr style="vertical-align: top;" lang="zh-CN">
<td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td>
<td colspan="2" style="background-color: white; color:black; text-align: center;">2017年9月30日 (六) 08:00的版本</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l15" >第15行：</td>
<td colspan="2" class="diff-lineno">第15行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#Nivolumab（纳武单抗），靶点PD-1，Nivolumab - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/nivolumab</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#Nivolumab（纳武单抗），靶点PD-1，Nivolumab - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/nivolumab</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#Pembrolizumab（派姆单抗），靶点PD-1，Pembrolizumab - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/pembrolizumab</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#Pembrolizumab（派姆单抗），靶点PD-1，Pembrolizumab - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/pembrolizumab</div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>#<del class="diffchange diffchange-inline">Bortezomib（硼替佐米），靶点Proteasome，Bortezomib </del>- National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/bortezomib</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>#<ins class="diffchange diffchange-inline">Bortezomib（硼替佐米），靶点Proteasome，中国已经上市 Bortezomib </ins>- National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/bortezomib</div></td></tr>
</table>
Jianjdandd
http://wiki.ch-chainclinic.com/index.php?title=%E9%9D%B6%E5%90%91%E8%8D%AF%E8%A1%8C%E4%B8%9A%E7%A0%94%E7%A9%B6&diff=11153&oldid=prev
Jianjdandd：/* 淋巴瘤 */
2017-09-30T07:59:51Z
<p><span dir="auto"><span class="autocomment">淋巴瘤</span></span></p>
<table class="diff diff-contentalign-left" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr style="vertical-align: top;" lang="zh-CN">
<td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td>
<td colspan="2" style="background-color: white; color:black; text-align: center;">2017年9月30日 (六) 07:59的版本</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l3" >第3行：</td>
<td colspan="2" class="diff-lineno">第3行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#New FDA Approved Drugs for 2017 | CenterWatch  http://www.centerwatch.com/drug-information/fda-approved-drugs/</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#New FDA Approved Drugs for 2017 | CenterWatch  http://www.centerwatch.com/drug-information/fda-approved-drugs/</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===淋巴瘤===</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===淋巴瘤===</div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>#Ibrutinib（依鲁替尼），靶点BTK，Ibrutinib (PCI-32765) | BTK 抑制剂 <del class="diffchange diffchange-inline">| 现货供应 | 美国品牌 | 免费采购电话400-668-6834 </del> http://www.selleck.cn/products/pci-32765.html</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>#Ibrutinib（依鲁替尼），靶点BTK，Ibrutinib (PCI-32765) | BTK 抑制剂  http://www.selleck.cn/products/pci-32765.html <ins class="diffchange diffchange-inline">Ibrutinib - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/ibrutinib</ins></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#Ibritumomab tiuxetan（替伊莫单抗），靶点CD20，抗癌新药Zevalin（ibritumomab tiuxetan）获FDA批准用于非何杰金氏淋巴瘤 - 诺本专科新特药房  http://www.nbdyf.com/zhongliuke/61.html  Ibritumomab Tiuxetan - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/ibritumomabtiuxetan</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#Ibritumomab tiuxetan（替伊莫单抗），靶点CD20，抗癌新药Zevalin（ibritumomab tiuxetan）获FDA批准用于非何杰金氏淋巴瘤 - 诺本专科新特药房  http://www.nbdyf.com/zhongliuke/61.html  Ibritumomab Tiuxetan - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/ibritumomabtiuxetan</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#Rituximab（利妥昔单抗），靶点CD20，中国已经上市，Rituximab - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/rituximab</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#Rituximab（利妥昔单抗），靶点CD20，中国已经上市，Rituximab - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/rituximab</div></td></tr>
</table>
Jianjdandd
http://wiki.ch-chainclinic.com/index.php?title=%E9%9D%B6%E5%90%91%E8%8D%AF%E8%A1%8C%E4%B8%9A%E7%A0%94%E7%A9%B6&diff=11152&oldid=prev
2017年9月30日 (六) 07:57 Jianjdandd
2017-09-30T07:57:44Z
<p></p>
<table class="diff diff-contentalign-left" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr style="vertical-align: top;" lang="zh-CN">
<td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td>
<td colspan="2" style="background-color: white; color:black; text-align: center;">2017年9月30日 (六) 07:57的版本</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l2" >第2行：</td>
<td colspan="2" class="diff-lineno">第2行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#Overview of Targeted Therapies for Cancer - My Cancer Genome  https://www.mycancergenome.org/content/molecular-medicine/overview-of-targeted-therapies-for-cancer</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#Overview of Targeted Therapies for Cancer - My Cancer Genome  https://www.mycancergenome.org/content/molecular-medicine/overview-of-targeted-therapies-for-cancer</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#New FDA Approved Drugs for 2017 | CenterWatch  http://www.centerwatch.com/drug-information/fda-approved-drugs/</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#New FDA Approved Drugs for 2017 | CenterWatch  http://www.centerwatch.com/drug-information/fda-approved-drugs/</div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">===淋巴瘤===</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#Ibrutinib（依鲁替尼），靶点BTK，Ibrutinib (PCI-32765) | BTK 抑制剂 | 现货供应 | 美国品牌 | 免费采购电话400-668-6834  http://www.selleck.cn/products/pci-32765.html</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#Ibritumomab tiuxetan（替伊莫单抗），靶点CD20，抗癌新药Zevalin（ibritumomab tiuxetan）获FDA批准用于非何杰金氏淋巴瘤 - 诺本专科新特药房  http://www.nbdyf.com/zhongliuke/61.html  Ibritumomab Tiuxetan - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/ibritumomabtiuxetan</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#Rituximab（利妥昔单抗），靶点CD20，中国已经上市，Rituximab - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/rituximab</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#Tositumomab（托西莫单抗）,靶点CD20，Tositumomab and Iodine I 131 Tositumomab - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/tositumomab-I131tositumomab</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#Obinutuzumab（奥滨尤妥珠单抗），靶点CD20，Obinutuzumab - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/obinutuzumab GAZYVA(obinutuzumab 中文名：奥滨尤妥珠单抗)注射剂_海得康海外新特药  http://www.headkonmed.com/headkonmed/products/2923118.html</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#Brentuximab vedotin（本妥昔单抗），靶点CD30，Brentuximab Vedotin - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/brentuximabvedotin</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#Romidepsin（罗米地辛），靶点HDAC，Romidepsin - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/romidepsin</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#Vorinostat（伏立诺他），靶点HDAC，Vorinostat - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/vorinostat</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#Belinostat，靶点HDAC，Belinostat - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/belinostat</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#Idelalisib，靶点PI3Kδ，Idelalisib - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/idelalisib</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#Nivolumab（纳武单抗），靶点PD-1，Nivolumab - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/nivolumab</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#Pembrolizumab（派姆单抗），靶点PD-1，Pembrolizumab - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/pembrolizumab</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#Bortezomib（硼替佐米），靶点Proteasome，Bortezomib - National Cancer Institute  https://www.cancer.gov/about-cancer/treatment/drugs/bortezomib</ins></div></td></tr>
</table>
Jianjdandd
http://wiki.ch-chainclinic.com/index.php?title=%E9%9D%B6%E5%90%91%E8%8D%AF%E8%A1%8C%E4%B8%9A%E7%A0%94%E7%A9%B6&diff=11151&oldid=prev
2017年9月30日 (六) 07:26 Jianjdandd
2017-09-30T07:26:04Z
<p></p>
<table class="diff diff-contentalign-left" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr style="vertical-align: top;" lang="zh-CN">
<td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td>
<td colspan="2" style="background-color: white; color:black; text-align: center;">2017年9月30日 (六) 07:26的版本</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1" >第1行：</td>
<td colspan="2" class="diff-lineno">第1行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#史上最全癌症靶向药（2017版）  https://mp.weixin.qq.com/s/7mpVHYy4QV8DZZFrU5Nc8w</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>#史上最全癌症靶向药（2017版）  https://mp.weixin.qq.com/s/7mpVHYy4QV8DZZFrU5Nc8w</div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#Overview of Targeted Therapies for Cancer - My Cancer Genome  https://www.mycancergenome.org/content/molecular-medicine/overview-of-targeted-therapies-for-cancer</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">#New FDA Approved Drugs for 2017 | CenterWatch  http://www.centerwatch.com/drug-information/fda-approved-drugs/</ins></div></td></tr>
</table>
Jianjdandd
http://wiki.ch-chainclinic.com/index.php?title=%E9%9D%B6%E5%90%91%E8%8D%AF%E8%A1%8C%E4%B8%9A%E7%A0%94%E7%A9%B6&diff=11150&oldid=prev
Jianjdandd：以“#史上最全癌症靶向药（2017版） https://mp.weixin.qq.com/s/7mpVHYy4QV8DZZFrU5Nc8w”为内容创建页面
2017-09-30T07:24:10Z
<p>以“#史上最全癌症靶向药（2017版） https://mp.weixin.qq.com/s/7mpVHYy4QV8DZZFrU5Nc8w”为内容创建页面</p>
<p><b>新页面</b></p><div>#史上最全癌症靶向药（2017版） https://mp.weixin.qq.com/s/7mpVHYy4QV8DZZFrU5Nc8w</div>
Jianjdandd